A Safety and Effectiveness Study of BL-ABT12 Multi-Purpose Solution for Use by Participants With Soft Contact Lenses
Public ClinicalTrials.gov record NCT03897751. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Safety and Effectiveness Study of a New Contact Lens Cleaning and Disinfecting Solution
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study is to evaluate the safety and effectiveness of ABT12 Multi-Purpose solution (Test) compared to COMPLETE® Multi-Purpose Solution Easy Rub® Formula ("COMPLETE Multi-Purpose Solution") when used by participants who are habitual contact lens wearers.
Study identification
- NCT ID
- NCT03897751
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 252 participants
Conditions and interventions
Conditions
Interventions
- ABT12 Multi-Purpose Solution Device
- COMPLETE Multi-Purpose Solution Device
- Sensitive Eyes® Rewetting Drops Device
Device
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 8, 2019 (Actual)
- Primary completion
- Aug 1, 2019 (Actual)
- Completion
- Aug 1, 2019 (Actual)
- Last update posted
- Mar 3, 2023
2019
United States locations
- U.S. sites
- 17
- U.S. states
- 13
- U.S. cities
- 17
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Bausch Site 1 | Birmingham | Alabama | 35216 | — |
| Bausch Site 2 | San Diego | California | 92123 | — |
| Bausch Site 3 | San Francisco | California | 94112 | — |
| Bausch Site 4 | Denver | Colorado | 80246 | — |
| Bausch Site 5 | Sarasota | Florida | 34232 | — |
| Bausch Site 6 | Decatur | Georgia | 30035 | — |
| Bausch Site 7 | Bloomington | Illinois | 61701 | — |
| Bausch Site 9 | Leavenworth | Kansas | 66048 | — |
| Bausch Site 8 | Pittsburg | Kansas | 66762 | — |
| Bausch Site 10 | Portland | Maine | 04101 | — |
| Bausch Site 11 | East Lansing | Michigan | 48823 | — |
| Bausch Site 12 | St Louis | Missouri | 63144 | — |
| Bausch Site 13 | Jamestown | New York | 14701 | — |
| Bausch Site 14 | Vestal | New York | 13850 | — |
| Bausch Site 15 | State College | Pennsylvania | 16801 | — |
| Bausch Site 17 | Brentwood | Tennessee | 37027 | — |
| Bausch Site 16 | Nashville | Tennessee | 37205 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03897751, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 3, 2023 · Synced Nov 2, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT03897751 live on ClinicalTrials.gov.